The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

• Status: Completed
• Trial end date: 2009-04-22

Summary

This is a study to determine the effectiveness and safety of donepezil hydrochloride (E2020) used to treat residents of assisted living facilities diagnosed with mild, moderate, or severe stage Alzheimer's disease.

• Phase: Phase 4

Details

• Lead Sponsor: Eisai Inc.
• Collaborator: Pfizer
• Treatments: Donepezil